STAGE I INVASIVE CERVIX CARCINOMA: S.S.K. EGE MATERNITY HOSPITAL EXPERIENCE

Volume: 39 Number: 1 March 1, 2000
  • Merih Hanhan
  • Enver Vardar
  • Refik Keleş
  • Ayşe Özbakkaloğlu
  • Murat İnal
Ege Journal of Medicine Cover
Ege Journal of Medicine
PDF Download
EN TR

STAGE I INVASIVE CERVIX CARCINOMA: S.S.K. EGE MATERNITY HOSPITAL EXPERIENCE

Abstract

To assess the risk factors that increase the recurrence rate in the cases treated forstage I cervical cancer. Department of Gynecologic Oncology, SSK Ege Maternity Teaching Hospital. 117 FIGO stage I cervix carcinoma cases were treated between 1986 and 1996 in our clinic. 64.9% (76 /117) of the patients primarily underWent radical hysterectomy and pelvic-paraaortic lymphadenectomy, while radiotherapy was performed to 66% (77/117) cases as phmary oradjuvant treatment modality. Treatment modalities, histologic type, lymph node involvement, invasion findings, and recurrences were documented. Epidermoid carcinoma was found in 103 patients (88.4 %), adenocarcinoma in 13 (10.7 %) and sarcoma in one (0.9%). Fourteen cases were stage Ia1, eight were stage Ia2 and 94 were stage Ib. Lymph node involvement was observed in 41% of the cases having parametrial involvement. Genitourinary fistula was the most encountered morbidity with the rate of 3.9 %. İt is recognised that recurrence and lymph node involvement rates increase when the depth invasion increases. 5-year survival rate was found as 88.56 % in ourseries.

Keywords

Details

Primary Language

Turkish

Subjects

-

Journal Section

-

Authors

Merih Hanhan

Enver Vardar

Refik Keleş

Ayşe Özbakkaloğlu

Murat İnal

Publication Date

March 1, 2000

Submission Date

March 1, 2000

Acceptance Date

-

Published in Issue

Year 2000 Volume: 39 Number: 1

IZ

https://izlik.org/JA75HZ79GJ

Cite

RIS / Bibtex
Vancouver
1.Merih Hanhan, Enver Vardar, Refik Keleş, Ayşe Özbakkaloğlu, Murat İnal. EVRE I İNVAZİV SERVİKS KARSİNOMLARI: SSK EGE DOĞUMEVİ VE KADIN HASTALIKLARI EĞİTİM HASTANESİ DENEYİMİ. EJM [Internet]. 2000 Mar. 1;39(1):51-5. Available from: https://izlik.org/JA75HZ79GJ

Ege Journal of Medicine enables the sharing of articles according to the Attribution-Non-Commercial-Share Alike 4.0 International (CC BY-NC-SA 4.0) license.